-
公开(公告)号:US09074980B2
公开(公告)日:2015-07-07
申请号:US13278716
申请日:2011-10-21
申请人: Tae-Hyun Yoon , Song-Hee Lee , Dong-Wook Kwon , Jong-Hoon Park , Hyun-Ju Yoo , Hyun-Woo Nho
发明人: Tae-Hyun Yoon , Song-Hee Lee , Dong-Wook Kwon , Jong-Hoon Park , Hyun-Ju Yoo , Hyun-Woo Nho
IPC分类号: C12Q1/18 , G01N21/64 , G01N21/29 , G01N15/14 , G01N15/04 , G01N33/50 , B82Y5/00 , B82Y35/00 , G01N15/00 , G01N15/10
CPC分类号: G01N15/1475 , G01N15/04 , G01N15/147 , G01N15/1484 , G01N21/6458 , G01N21/648 , G01N33/5014 , G01N2015/0038 , G01N2015/0092 , G01N2015/1075 , G01N2015/1486 , G01N2015/1497 , G01N2510/00
摘要: The present invention relates to a method for the toxicity assessment of nano-materials, and more specifically, it is relates to an objective, reproducible and accurate assessment method for the unbiased toxicity testings of nano-materials, which minimize artifacts of the conventional methods for the toxicity assessment of the nano-materials by considering the dose characteristics of the nano-material itself using Selective multi-Plane Illumination Microcopy (SPIM); and the response characteristics of the nano-material using the improved or novel cellular responses assessment methods for nano-materials (e.g., modified MTT assay using image cytometric analysis, normal-inverted exposure apparatus, and modified flow cytometry), and a system and an apparatus thereof.
摘要翻译: 本发明涉及一种纳米材料的毒性评估方法,更具体地说,本发明涉及一种用于纳米材料的无偏差毒性试验的客观,可重现和准确的评估方法,其使常规方法的伪影最小化 通过使用选择性多平面照明显微镜(SPIM)考虑纳米材料本身的剂量特征,对纳米材料的毒性评估; 以及纳米材料的改进或新型细胞应答评估方法(例如,使用图像细胞计数分析,正常反转曝光装置和修饰的流式细胞术的修饰MTT测定)的纳米材料的响应特性,以及系统和 装置。
-
公开(公告)号:US20120219985A1
公开(公告)日:2012-08-30
申请号:US13278716
申请日:2011-10-21
申请人: Tae-Hyun Yoon , Song-Hee Lee , Dong-Wook Kwon , Jong-Hoon Park , Hyun-Ju Yoo , Hyun-Woo Nho
发明人: Tae-Hyun Yoon , Song-Hee Lee , Dong-Wook Kwon , Jong-Hoon Park , Hyun-Ju Yoo , Hyun-Woo Nho
CPC分类号: G01N15/1475 , G01N15/04 , G01N15/147 , G01N15/1484 , G01N21/6458 , G01N21/648 , G01N33/5014 , G01N2015/0038 , G01N2015/0092 , G01N2015/1075 , G01N2015/1486 , G01N2015/1497 , G01N2510/00
摘要: The present invention relates to a method for the toxicity assessment of nano-materials, and more specifically, it is relates to an objective, reproducible and accurate assessment method for the unbiased toxicity testings of nano-materials, which minimize artifacts of the conventional methods for the toxicity assessment of the nano-materials by considering the dose characteristics of the nano-material itself using Selective multi-Plane Illumination Microcopy (SPIM); and the response characteristics of the nano-material using the improved or novel cellular responses assessment methods for nano-materials (e.g., modified MTT assay using image cytometric analysis, normal-inverted exposure apparatus, and modified flow cytometry), and a system and an apparatus thereof.
摘要翻译: 本发明涉及一种纳米材料的毒性评估方法,更具体地说,本发明涉及一种用于纳米材料的无偏差毒性试验的客观,可重现和准确的评估方法,其使常规方法的伪影最小化 通过使用选择性多平面照明显微镜(SPIM)考虑纳米材料本身的剂量特征,对纳米材料的毒性评估; 以及纳米材料的改进或新型细胞应答评估方法(例如,使用图像细胞计数分析,正常反转曝光装置和修饰的流式细胞术的修饰MTT测定)的纳米材料的响应特性,以及系统和 装置。
-
公开(公告)号:US20090186039A1
公开(公告)日:2009-07-23
申请号:US12355747
申请日:2009-01-16
申请人: Sung-Key JANG , Song-Hee Lee
发明人: Sung-Key JANG , Song-Hee Lee
IPC分类号: A61K39/395 , A61K31/711 , A61P31/12 , C12Q1/02
CPC分类号: G01N33/68 , A61K31/711 , G01N33/576 , G01N2500/00
摘要: A novel use of GRP 94 in treatment of virus infection is provided. More specifically, a method of inhibiting virus infection by inhibiting expression of GRP 94 and/or inactivating activity of GRP 94, and a method of developing drugs for preventing and/or treating virus infection and/or diseases caused by virus infection by using GRP 94 as a target are provided.
摘要翻译: 提供GRP 94在病毒感染治疗中的新用途。 更具体地,通过抑制GRP94的表达和/或灭活GRP94的活性来抑制病毒感染的方法,以及通过使用GRP 94来开发用于预防和/或治疗由病毒感染引起的病毒感染和/或疾病的药物的方法 作为目标提供。
-
公开(公告)号:US20100273144A1
公开(公告)日:2010-10-28
申请号:US12814413
申请日:2010-06-11
申请人: Sung-Key Jang , Song-Hee Lee
发明人: Sung-Key Jang , Song-Hee Lee
IPC分类号: C12Q1/70
CPC分类号: G01N33/68 , A61K31/711 , G01N33/576 , G01N2500/00
摘要: A novel use of GRP 94 in treatment of virus infection is provided. More specifically, a method of inhibiting virus infection by inhibiting expression of GRP 94 and/or inactivating activity of GRP 94, and a method of developing drugs for preventing and/or treating virus infection and/or diseases caused by virus infection by using GRP 94 as a target are provided.
摘要翻译: 提供GRP 94在病毒感染治疗中的新用途。 更具体地,通过抑制GRP94的表达和/或灭活GRP94的活性来抑制病毒感染的方法,以及通过使用GRP 94来开发用于预防和/或治疗由病毒感染引起的病毒感染和/或疾病的药物的方法 作为目标提供。
-
-
-